{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:54:11Z","timestamp":1787064851897,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:00:00Z","timestamp":1720310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2023RC140"],"award-info":[{"award-number":["2023RC140"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012175","name":"Zhejiang Administration Bureau of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2021AX002"],"award-info":[{"award-number":["2021AX002"]}],"id":[{"id":"10.13039\/501100012175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012175","name":"Zhejiang Administration Bureau of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["GZY-ZJ-SY-2402"],"award-info":[{"award-number":["GZY-ZJ-SY-2402"]}],"id":[{"id":"10.13039\/501100012175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074093"],"award-info":[{"award-number":["82074093"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.biopha.2024.117105","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T21:14:18Z","timestamp":1720905258000},"page":"117105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Spinosad blocks CHRNA5 mediated EGFR signaling pathway activation to inhibit lung adenocarcinoma proliferation"],"prefix":"10.1016","volume":"177","author":[{"given":"Hongling","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jili","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3296-6868","authenticated-orcid":false,"given":"Mingqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2024.117105_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.biopha.2024.117105_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.hoc.2016.08.006","article-title":"Lung cancer biomarkers[J]","volume":"31","author":"Villalobos","year":"2017","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"12","key":"10.1016\/j.biopha.2024.117105_bib3","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1002\/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#","article-title":"Small adenocarcinoma of the lung. Histologic characteristics and prognosis[J]","volume":"75","author":"Noguchi","year":"1995","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.biopha.2024.117105_bib4","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","article-title":"Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis[J]","volume":"21","author":"Hirsch","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117105_bib5","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/chem.200902963","article-title":"Reversible dimerization of EGFR revealed by single-molecule fluorescence imaging using quantum dots[J]","volume":"16","author":"Kawashima","year":"2010","journal-title":"Chem. \u2013A Eur. J."},{"key":"10.1016\/j.biopha.2024.117105_bib6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.compbiolchem.2018.07.018","article-title":"Stochasticity and robustness analysis of microRNA-mediated ERK signaling network[J]","volume":"76","author":"Zhou","year":"2018","journal-title":"Comput. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2024.117105_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195513","article-title":"Dynamics and control of the ERK signaling pathway: sensitivity, bistability, and oscillations[J]","volume":"13","author":"Arkun","year":"2018","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1016\/j.biopha.2024.117105_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cell.2008.11.051","article-title":"Digital signaling and hysteresis characterize ras activation in lymphoid cells","volume":"136","author":"Das","year":"2009","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biopha.2024.117105_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"Erlotinib in previously treated non-small-cell lung cancer","volume":"353","author":"Shepherd","year":"2005","journal-title":"N. Engl. J. Med"},{"issue":"9496","key":"10.1016\/j.biopha.2024.117105_bib10","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(05)67625-8","article-title":"Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)[J]","volume":"366","author":"Thatcher","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biopha.2024.117105_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s13402-022-00696-3","article-title":"Activation of the HSP27-AKT axis contributes to gefitinib resistance in non-small cell lung cancer cells independent of EGFR mutations[J]","volume":"45","author":"Choi","year":"2022","journal-title":"Cell Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117105_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1158\/1541-7786.MCR-13-0541","article-title":"Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers","volume":"12","author":"Schaal","year":"2014","journal-title":"Mol. Cancer Res"},{"issue":"4","key":"10.1016\/j.biopha.2024.117105_bib13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.5306\/wjco.v5.i4.667","article-title":"Acetylcholine receptor pathway in lung cancer: New twists to an old story","volume":"5","author":"Niu","year":"2014","journal-title":"World J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117105_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2015.01.017","article-title":"Nicotine induces resistance to erlotinib via cross-talk between alpha 1 nAChR and EGFR in the non-small cell lung cancer xenograft model","volume":"88","author":"Li","year":"2015","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2024.117105_bib15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/joim.12454","article-title":"Gene variance in the nicotinic receptor cluster (CHRNA5-CHRNA3-CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers[J]","volume":"279","author":"Hallden","year":"2016","journal-title":"J. Intern Med"},{"issue":"3","key":"10.1016\/j.biopha.2024.117105_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tips.2007.12.006","article-title":"Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis[J]","volume":"29","author":"Egleton","year":"2008","journal-title":"Trends Pharm. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2024.117105_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/carcin\/bgac003","article-title":"alpha5-nAChR associated with Ly6E modulates cell migration via TGF-beta1\/Smad signaling in non-small cell lung cancer[J]","volume":"43","author":"Zhang","year":"2022","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.biopha.2024.117105_bib18","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1111\/jcmm.14941","article-title":". alpha5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1\/Csn5 signalling in lung cancer[J]","volume":"24","author":"Chen","year":"2020","journal-title":"J. Cell Mol. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.117105_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-022-00934-z","article-title":"Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3\/Jab1-PD-L1 signalling[J]","volume":"20","author":"Zhu","year":"2022","journal-title":"Cell Commun. Signal."},{"issue":"18","key":"10.1016\/j.biopha.2024.117105_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186829","article-title":"Low-dose nicotine activates EGFR Signaling via alpha5-nAChR and promotes lung adenocarcinoma progression[J]","volume":"21","author":"Wang","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117105_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00573","article-title":"Alpha5 nicotinic acetylcholine receptor contributes to nicotine-induced lung cancer development and progression[J]","volume":"8","author":"Sun","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.117105_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pharmthera.2018.10.002","article-title":"Acetylcholine signaling system in progression of lung cancers","volume":"194","author":"Friedman","year":"2019","journal-title":"J. ]. Pharmacol. Ther."},{"issue":"13","key":"10.1016\/j.biopha.2024.117105_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136818","article-title":"Regulation of immune functions by non-neuronal acetylcholine (ACh) via muscarinic and nicotinic ACh receptors[J]","volume":"22","author":"Mashimo","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2024.117105_bib24","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1378\/chest.112.6.1474","article-title":"Cigarette smoking and histologic type of lung cancer in men[J]","volume":"112","author":"Barbone","year":"1997","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.biopha.2024.117105_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.21.01626","article-title":"Targeted therapies for lung cancer patients with oncogenic driver molecular alterations[J]","volume":"40","author":"Tan","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117105_bib26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1200\/JCO.21.01497","article-title":"First-line immunotherapy for non-small-cell lung cancer[J]","volume":"40","author":"Reck","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117105_bib27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1200\/JCO.21.01589","article-title":"Preoperative and postoperative systemic therapy for operable non-small-cell lung cancer[J]","volume":"40","author":"Chaft","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117105_bib28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1200\/JCO.21.01639","article-title":"Radiation and systemic therapy for limited-stage small-cell lung cancer[J]","volume":"40","author":"Bogart","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.biopha.2024.117105_bib29","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in resected EGFR-mutated non-small-cell lung cancer[J]","volume":"383","author":"Wu","year":"2020","journal-title":"N. Engl. J. Med"},{"issue":"23","key":"10.1016\/j.biopha.2024.117105_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315056","article-title":"Non-small cell lung cancer targeted therapy: drugs and mechanisms of drug resistance[J]","volume":"23","author":"Wu","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2024.117105_bib31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.6004\/jnccn.2022.0025","article-title":"Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology[J]","volume":"20","author":"Ettinger","year":"2022","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"2","key":"10.1016\/j.biopha.2024.117105_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11020140","article-title":"The risks and benefits of immune checkpoint blockade in anti-AChR antibody-seropositive non-small cell lung cancer patients[J]","volume":"11","author":"Saruwatari","year":"2019","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.biopha.2024.117105_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jgg.2017.03.003","article-title":"Reciprocal activation of alpha5-nAChR and STAT3 in nicotine-induced human lung cancer cell proliferation[J]","volume":"44","author":"Zhang","year":"2017","journal-title":"J. Genet Genom."},{"issue":"4","key":"10.1016\/j.biopha.2024.117105_bib34","first-page":"877","article-title":"Carbon dioxide potentiates the mitogenic effects of nicotine and its carcinogenic derivative, NNK, in normal and neoplastic neuroendocrine lung cells via stimulation of autocrine and protein kinase C-dependent mitogenic pathways","volume":"15","author":"Schuller","year":"1994","journal-title":"Neurotoxicology"},{"issue":"3","key":"10.1016\/j.biopha.2024.117105_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrc2590","article-title":"Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?[J]","volume":"9","author":"Schuller","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.117105_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106813","article-title":"Advances in small molecule selective ligands for heteromeric nicotinic acetylcholine receptors[J]","volume":"194","author":"Matera","year":"2023","journal-title":"Pharm. Res"},{"issue":"4","key":"10.1016\/j.biopha.2024.117105_bib37","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s11418-021-01544-8","article-title":"Effects of nicotinic acetylcholine receptor-activating alkaloids on anxiety-like behavior in zebrafish[J]","volume":"75","author":"Alzualde","year":"2021","journal-title":"J. Nat. Med"},{"issue":"2","key":"10.1016\/j.biopha.2024.117105_bib38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1208\/s12248-012-9328-7","article-title":"Population analyses of efficacy and safety of ABT-594 in subjects with diabetic peripheral neuropathic pain[J]","volume":"14","author":"Dutta","year":"2012","journal-title":"AAPS J."},{"issue":"3-4","key":"10.1016\/j.biopha.2024.117105_bib39","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10571-005-3968-4","article-title":"Nicotinic agonists, antagonists, and modulators from natural sources[J]","volume":"25","author":"Daly","year":"2005","journal-title":"Cell Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.biopha.2024.117105_bib40","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3390\/toxins7051683","article-title":"Natural compounds interacting with nicotinic acetylcholine receptors: from low-molecular weight ones to peptides and proteins[J]","volume":"7","author":"Kudryavtsev","year":"2015","journal-title":"Toxins"},{"key":"10.1016\/j.biopha.2024.117105_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.609005","article-title":"Structure-function of neuronal nicotinic acetylcholine receptor inhibitors derived from natural toxins[J]","volume":"14","author":"Ho","year":"2020","journal-title":"Front Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2024.117105_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00018-023-04742-7","article-title":"Acetylcholine promotes chronic stress-induced lung adenocarcinoma progression via alpha5-nAChR\/FHIT pathway[J]","volume":"80","author":"Jiao","year":"2023","journal-title":"Cell Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.biopha.2024.117105_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3055","article-title":"Sensitization of epithelial growth factor receptors by nicotine exposure to promote breast cancer cell growth[J]","volume":"13","author":"Nishioka","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.117105_bib44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1073\/pnas.91.1.167","article-title":"Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2\/ASH association and retains mitogenic activity[J]","volume":"91","author":"Gotoh","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"28","key":"10.1016\/j.biopha.2024.117105_bib45","doi-asserted-by":"crossref","first-page":"18674","DOI":"10.1016\/S0021-9258(17)32363-3","article-title":"Tyrosines 1148 and 1173 of activated human epidermal growth factor receptors are binding sites of Shc in intact cells[J]","volume":"269","author":"Okabayashi","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2024.117105_bib46","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.bcp.2011.05.020","article-title":"Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer[J]","volume":"82","author":"Improgo","year":"2011","journal-title":"Biochem Pharm."},{"issue":"12","key":"10.1016\/j.biopha.2024.117105_bib47","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1164\/rccm.200806-908OC","article-title":"Inhibition of nonneuronal alpha7-nicotinic receptor for lung cancer treatment[J]","volume":"179","author":"Paleari","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.117105_bib48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12985-017-0852-z","article-title":"Recombinant Newcastle disease virus rL-RVG enhances the apoptosis and inhibits the migration of A549 lung adenocarcinoma cells via regulating alpha 7 nicotinic acetylcholine receptors in vitro[J]","volume":"14","author":"Yan","year":"2017","journal-title":"Virol. J."},{"issue":"12","key":"10.1016\/j.biopha.2024.117105_bib49","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s004320100289","article-title":"Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1\/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells[J]","volume":"127","author":"Jull","year":"2001","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2024.117105_bib50","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.biocel.2009.01.013","article-title":"Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis[J]","volume":"41","author":"Arias","year":"2009","journal-title":"Int J. Biochem Cell Biol."},{"issue":"8","key":"10.1016\/j.biopha.2024.117105_bib51","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1002\/ps.6073","article-title":"The spinosyns, spinosad, spinetoram, and synthetic spinosyn mimics - discovery, exploration, and evolution of a natural product chemistry and the impact of computational tools[J]","volume":"77","author":"Sparks","year":"2021","journal-title":"Pest Manag Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.117105_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/10937404.2019.1689878","article-title":"Properties, toxicity and current applications of the biolarvicide spinosad[J]","volume":"23","author":"Santos","year":"2020","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2024.117105_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pestbp.2011.11.004","article-title":"Resistance and cross-resistance to the spinosyns\u2013a review and analysis[J]","volume":"102","author":"Sparks","year":"2012","journal-title":"Pestic. Biochem. Physiol."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2024.117213","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224009892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224009892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:02:25Z","timestamp":1782172945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224009892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":53,"alternative-id":["S0753332224009892"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117105","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spinosad blocks CHRNA5 mediated EGFR signaling pathway activation to inhibit lung adenocarcinoma proliferation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117105"}}